Profile of Prof. Dr. rer. biol. hum., Dipl.-Math. Eva Hoster

Professor for medical biometry with a focus on clinical epidemiology; Interim Chair of Biometry and Bioinformatics and as Deputy Director of the IBE

Brief CV

  • 2020 Certificate „Biometry in Medicine“ by GMDS
  • Since 2020 professor for medical biometry with focus on clinical epidemiology
  • 2017 habilitation in clinical epidemiology and medical biometry at the faculty of medicine of the LMU Munich with the cumulative thesis “Evaluation of clinical and biological prognostic factors, establishment of prognostic models, and therapeutic research in malignant lymphomas and leukemias” (https://edoc.ub.uni-muenchen.de/21506/)
  • 2008 doctoral grade in human biology (“summa cum laude”) with the thesis “Derivation of a new prognostic index for patients with advanced stage mantle cell lymphoma” (https://edoc.ub.uni-muenchen.de/9271/)
  • 2002-2019 biostatistician and clinical epidemiologist at the hematology study center of the LMU University Hospital Munich and research associate at the IBE of the LMU Munich
  • 2002 diploma in mathematics
  • 1997-2002 studies of human medicine at LMU Munich and TU Munich, first federal exam 2001
  • 1992-1997 and 2000-2002 studies of mathematics with minor theoretical physics at LMU Munich and the Rheinische Friedrich-Wilhelms-Universität Bonn

Teaching

Supervision of Bachelor’s and Master’s Theses

  • Maria Blanco (Master Statistik, 2024): "Evaluation of statistical tests to detect survival probability differences using stratified Kaplan-Meier estimates with different variance estimators and weights"
  • Katja Gutmair (Master Public Health, 2023): “Comparison of clinical outcomes between two first line rituximab-containing chemotherapy regimens, R-CHOP vs. R-B, followed by maintenance rituximab, in transplant-ineligible patients with mantle-cell lymphoma in an international study with pooled, prospective cohorts”
  • Josef Pernerstorfer (Bachelor Statistik, 2023): “Statistical analysis and reporting of adverse events in clinical trials: recommendations, current practice and relevance for interpretation”
  • Katja Gutmair (Bachelor Statistik, 2021): “Phase II Studies in Oncology: Current Practices of Choosing Group Configuration and Statistical Design”
  • Peirong Huang (Bachelor Statistik, 2020): “A comparison of estimation methods for time to event outcomes in a clinical trial with two-stage randomization“

Supervision of Dissertations

Supervision of ongoing dissertations

  • Katja Gutmair (PhD Medical Research): MULTIPLY
  • Dan Huang (PhD Medical Research): “Constructing estimands for overall survival within causal frame work for dynamic treatment schemes in oncology: imulation and clinical trial examples”
  • Linmiao Jiang (PhD Medical Research): “Long-term Survival Trends in Advanced Stage Mantle Cell Lymphoma – A Longitudinal Analysis of GLSG / European MCL Network Clinical Trials, 1996-2010”

Member of Thesis Advisory Committees (TAC) of ongoing dissertations

  • Lena Cimbalnik (Dr. med): “Etablierung neuer Assays zur Bestimmung der molekularen messbaren Resterkrankung bei Leukämien”
  • Megan Schroeder (PhD Medical Research): “Optimization of Eligibility Criteria and Enrichment Strategies of Heart Failure Trials: Deep-dive Into Sex Differences and NT-proBNP Values with Trial and Registry data”
  • Liye Lai (PhD Medical Research): “DNA methylation and hydroxymethylation in association with risk factors for cardiovascular diseases”

Research areas

  • Prognostic models for hematological malignancies
  • Biostatistical planning, supervision and analysis of clinical studies
  • Application of statistical methods in clinical research
  • You will find my publications via ORCID, WOS and PubMed

Committee memberships

  • Member of the steering committee of the German Lymphoma Alliance (GLA)
  • Member of the working groups Biometry and bioinformatics, indolent lymphomas, mantle cell lymphoma and biological research of the German Lymphoma Alliance (GLA)
  • Voting member on behalf of the German Society for Medical Informatics, Biometry, and Epidemiology (GMDS) for the Update of the Clinical Practice Guideline on Hodgkin Lymphoma
  • Author and voting member on behalf of the German Society for Medical Informatics, Biometry, and Epidemiology (GMDS) for the Clinical Practice Guideline on Follicular Lymphoma
  • Member of the Data Safety Monitoring Committee (DSMC) of academic clinical studies
  • Advisory board member of the Kompetenznetz Maligne Lymphome (KML)
  • Member of the selection committee for the Medical & Clinician Scientist Program (MCSP) at LMU
  • Member of the LMU Open Science Initiative in Medicine (OSIM-LMU)

Publications